Remdesivir, an antiviral medication, became an early promising therapeutic candidate for
coronavirus disease 2019 (COVID-19) due to its ability to inhibit the virus in vitro. Current …

Objectives This study investigated remdesivir's clinical use to provide direct evidence of
effectiveness for a low-middle income Asian setting. Design A one-to-one propensity score …

Background The impact of remdesivir (RDV) on mortality rates in coronavirus disease 2019
(COVID-19) is controversial, and the mortality effect in subgroups of baseline disease …

The global COVID-19 pandemic is currently underway. To date, there are about 1.49 million
dead and 64.5 million people infected [1]. In this period of global pandemic, several …

Importance SARS-CoV-2, which causes COVID-19, poses considerable morbidity and
mortality risks. Studies using data collected during routine clinical practice can supplement …

Importance/Background: During current public health emergency of COVID-19 pandemic,
repurposing of existing antiviral drugs may be an efficient strategy since there is no proven …

Background Immunocompromised patients are at high risk of severe coronavirus disease
2019 (COVID-19) and death, yet treatment strategies for immunocompromised patients …

Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …

Purpose Preliminary data suggest that remdesivir may influence the course of COVID-19
according to the duration of pre-admission symptoms. We aim to evaluate whether early use …

Importance Clinical effectiveness data on remdesivir are urgently needed, especially among
diverse populations and in combination with other therapies. Objective To examine whether …